{"schema_version":"1","generated_at":"2026-11-08T19:02:17.717Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kanika-nair","json_url":"https://www.findmykol.com/kol/kanika-nair/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kanika-nair","name":"Kanika Nair","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cleveland Clinic","institution_url":"https://www.findmykol.com/institution/cleveland-clinic","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1275952830","orcid":"0009-0002-5090-4801","openalex":"A5113292381"},"summary":"Kanika Nair is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 41 publications with 296 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":41,"cited_by_count":296,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":10,"shown":3,"withheld":7,"rows":[{"payer":"Moderna","program_year":2025,"amount_usd":233686.7,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275952830"},{"payer":"Amgen","program_year":2025,"amount_usd":100706.38,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275952830"},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":4504.11,"payment_count":12,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275952830"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1275952830","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":41.9,"classes_total":2,"classes":[{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":21.7,"drugs":[{"name":"Creon","share_pct":100}],"max_beneficiaries":null},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":20.2,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":25}]},{"area":"Nervous system","share_pct":30.8,"classes_total":2,"classes":[{"class":"Atypical Antipsychotic","setting":"prescribed","share_pct":16.7,"drugs":[{"name":"Olanzapine","share_pct":100}],"max_beneficiaries":12},{"class":"Phenothiazine","setting":"prescribed","share_pct":14.1,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":21}]},{"area":"Blood & clotting","share_pct":12.1,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":12.1,"drugs":[{"name":"Eliquis","share_pct":50},{"name":"Xarelto","share_pct":50}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":7.3,"facility_pct":92.7},"source":"medicare"},"publications":{"total":41,"shown":5,"withheld":36,"matched_by":"OpenAlex author record","recent":[{"title":"Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline","year":2026,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op-26-00311","status":"verified"},{"title":"Multimodality neoadjuvant downstaging therapy before liver transplantation for colorectal liver metastasis: Real-world data from the Cleveland Clinic.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.3594","status":"verified"},{"title":"Adagrasib in the treatment of colorectal cancer","year":2025,"journal":"Future Oncology","source_url":"https://doi.org/10.1080/14796694.2025.2524311","status":"verified"},{"title":"Sex, racial and ethnic disparities in early-onset versus average-onset gastrointestinal cancers: A population-based analysis.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e15683","status":"verified"},{"title":"Is PPM1D a potential driver of myeloid malignancy transformation in neuroendocrine tumor (NET) patients: An underrecognized malignant CHIPeRpetRaTor?","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-6711","status":"verified"}],"source":"works"},"contact":{"address_1":"10201 CARNEGIE AVE # CA6-164","city":"Cleveland","state":"OH","zip":"441062130","phone":"216-444-2200","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1275952830","source":"identity"},"similar":[{"name":"Steven Nissen","slug":"steven-nissen","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/steven-nissen","json_url":"https://www.findmykol.com/kol/steven-nissen/profile.json"},{"name":"Samir Kapadia","slug":"samir-kapadia","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/samir-kapadia","json_url":"https://www.findmykol.com/kol/samir-kapadia/profile.json"},{"name":"Mina Chung","slug":"mina-chung","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mina-chung","json_url":"https://www.findmykol.com/kol/mina-chung/profile.json"},{"name":"Serpil Erzurum","slug":"serpil-erzurum","institution":"Cleveland Clinic","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/serpil-erzurum","json_url":"https://www.findmykol.com/kol/serpil-erzurum/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":7,"publications":36}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-07-15","provider_certified":"2021-07-15","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}